Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation

Details for Australian Patent Application No. 2004212710 (hide)

Owner Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.

Inventors Hart, Stefan; Ullrich, Axel; Gschwind, Andreas

Agent Davies Collison Cave

Pub. Number AU-B-2004212710

PCT Pub. Number WO2004/073734

Priority 030 03 935.8 21.02.03 EP

Filing date 20 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 2 April 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/485 (2006.01) Peptides having more than 20 amino acids

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/073734 Priority application(s): WO2004/073734

2 April 2009 Application Accepted

  Published as AU-B-2004212710

30 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212726-Luminous optical laryngoscope comprising built-in fluid-extraction device

2004212704-Use of palonosetron treating postoperative nausea and vomiting